Some post-translationally modified proteins are highly enriched in protein aggregates in neurodegenerative diseases, e.g., phosphorylated tau in AD and FTD, and phosphorylated TDP-43 in ALS. This evidence concerns the gene MAPT and Alzheimer disease.